MCV vs RDW: Detecting Iron Depletion on Cycle

MCV (mean corpuscular volume) and RDW (red cell distribution width) are red cell indices reported on every complete blood count. Individually, each tells you something about red cell quality. Together, their pattern during accelerated erythropoiesis on AAS is one of the most clinically useful signals in the bodybuilder's bloodwork panel.

MCV is the average volume of a red blood cell, measured in femtolitres (fL). It reflects the size of cells already in circulation, which represents a population produced over the previous 90-120 days (the lifespan of a red blood cell). A normal MCV in the context of AAS use means the current circulating red cell population is appropriately sized. A falling MCV means new cells are being made smaller, which almost always signals iron deficiency.

RDW is the coefficient of variation in red cell volume across the entire circulating population. A low RDW means all cells are similar in size. A high RDW means there is a wide spread: the bone marrow is producing cells of mixed sizes. This heterogeneity is the earliest detectable sign of iron depletion, appearing before MCV begins to fall.

The sequence that matters: On cycle, bone marrow drives accelerated erythropoiesis. If iron supply falls short of this increased demand, new red cells are made smaller. The older, larger, iron-replete cells are still in circulation for another 90-120 days. The mixed population of old normal-sized cells and new smaller cells causes RDW to rise before MCV drops. Catching this RDW rise early gives a window to address iron status before frank microcytosis develops.

What each measures:

• MCV: The mean (average) volume of red blood cells, in femtolitres. A population average. Does not capture variability.
• RDW: The coefficient of variation in red cell size across the sample. A measure of heterogeneity. Captures the spread of the distribution, not the average.

Timing of change in iron depletion:

• RDW rises first: When iron supply falls below erythropoietic demand, new cells produced from that point are smaller. Older, larger, iron-replete cells remain in circulation for weeks to months. The mixed population widens the size distribution, raising RDW before the average shifts.
• MCV falls later: MCV only drops when smaller cells begin to numerically dominate the circulating population. This requires sufficient turnover of the older cells, typically 6-12 weeks after iron depletion begins. By the time MCV falls, iron depletion is well established.

Iron deficiency versus B12/folate deficiency:

• Iron deficiency: Produces small cells (microcytosis). MCV falls. RDW rises first, then MCV drops. Both eventually become abnormal.
• B12 or folate deficiency: Produces large cells (macrocytosis). MCV rises. RDW also rises early, for the same reason: a mixed population of older normal cells and newer, larger cells before the average shifts.
• Mixed deficiency (iron plus B12/folate): The opposing size effects can produce a normal MCV while RDW is markedly elevated. This is the classic "normal MCV, high RDW" combination that should trigger investigation for simultaneous iron and B12/folate depletion.

Sensitivity and specificity:

• RDW: High sensitivity for iron deficiency. Rises before ferritin drops to classically deficient levels in the setting of accelerated erythropoiesis. Less specific: also elevated in haemolysis, recent transfusion, and mixed deficiency states.
• MCV: High specificity for iron deficiency when low (microcytosis has a short differential). Low sensitivity: a normal MCV does not rule out early iron deficiency.

Normal ranges and interpretation on cycle:

• MCV: 80-100 fL. On AAS without iron or B12 issues, MCV typically stays stable. Testosterone itself does not change MCV significantly.
• RDW: 11.5-14.5% (RDW-CV). A rising RDW on cycle, even within the normal range (say 13% trending toward 14%), should prompt ferritin and iron saturation testing.

Use RDW as your on-cycle early warning marker:

• RDW rises before MCV changes and before ferritin drops to classically deficient levels
• Track RDW at every blood panel draw and note the trend, not just the absolute value
• A rising RDW on cycle (even within the normal range) is an indication to check ferritin, serum iron, and transferrin saturation
• RDW trending above 14% in an AAS user on active cycle is an early iron depletion signal until proven otherwise

Use MCV to confirm and characterise the deficiency type:

• A falling MCV confirms iron deficiency (microcytosis)
• A rising MCV points to B12 or folate deficiency (macrocytosis)
• A normal MCV with high RDW suggests either early iron depletion, early B12/folate deficiency, or a mixed deficiency pattern
• MCV changes lag 6-12 weeks behind RDW, making it a confirmatory rather than screening marker

Use both together for pattern recognition:

• Rising RDW, stable MCV: early iron or B12/folate depletion; check both
• Rising RDW, falling MCV: established iron deficiency; begin supplementation or reduce phlebotomy frequency
• Rising RDW, rising MCV: B12 or folate deficiency; check B12 and folate levels
• Markedly elevated RDW with normal MCV and no other findings: rule out mixed deficiency, haemolysis, or recent blood loss

When to act without waiting for MCV to fall:

• On a high erythropoietic compound (boldenone, high-dose testosterone, or with EPO), do not wait for MCV to drop
• A rising RDW with ferritin below 50 ng/mL warrants iron supplementation even if MCV is still normal
• Waiting for MCV to fall means waiting 6-12 additional weeks while new cells are being produced iron-depleted